Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3‐nitropropionic acid neurotoxicity

Altered energy metabolism, including reductions in activities of the key mitochondrial enzymes α‐ketoglutarate dehydrogenase complex (KGDHC) and pyruvate dehydrogenase complex (PDHC), are characteristic of many neurodegenerative disorders including Alzheimer's Disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). Dihydrolipoamide dehydrogenase is a critical subunit of KGDHC and PDHC. We tested whether mice that are deficient in dihydrolipoamide dehydrogenase (Dld+/–) show increased vulnerability to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), malonate and 3‐nitropropionic acid (3‐NP), which have been proposed for use in models of PD and HD. Administration of MPTP resulted in significantly greater depletion of tyrosine hydroxylase‐positive neurons in the substantia nigra of Dld+/– mice than that seen in wild‐type littermate controls. Striatal lesion volumes produced by malonate and 3‐NP were significantly increased in Dld+/– mice. Studies of isolated brain mitochondria treated with 3‐NP showed that both succinate‐supported respiration and membrane potential were suppressed to a greater extent in Dld+/– mice. KGDHC activity was also found to be reduced in putamen from patients with HD. These findings provide further evidence that mitochondrial defects may contribute to the pathogenesis of neurodegenerative diseases.

[1]  J. Blass,et al.  Abnormality of the α‐ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease , 1994 .

[2]  D. Perl,et al.  Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.

[3]  J. Blass,et al.  Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. , 1988, Archives of neurology.

[4]  D. Edmondson,et al.  Inactivation of succinate dehydrogenase by 3-nitropropionate. , 1979, The Journal of biological chemistry.

[5]  R. Butterworth,et al.  Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease , 1990, Metabolic Brain Disease.

[6]  G. Reynolds,et al.  Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases , 1985, Journal of the Neurological Sciences.

[7]  J. Trojanowski,et al.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.

[8]  Y. Mizuno,et al.  Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain , 1988, Journal of the Neurological Sciences.

[9]  G E Gibson,et al.  α‐ketoglutarate dehydrogenase in alzheimer brains bearing the APP670/671 mutation , 1998 .

[10]  C. Marsden,et al.  Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1995, Neuroreport.

[11]  C. Ríos,et al.  Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease , 2000, Brain Research.

[12]  R. Rosenthal,et al.  Cerebral Ischemia and Reperfusion: Prevention of Brain Mitochondrial Injury by Lidoflazine , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A H Schapira,et al.  Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse , 2000, Annals of neurology.

[14]  N. Hattori,et al.  Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. , 1995, Biochimica et biophysica acta.

[15]  S. Kish,et al.  Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders , 1999, Journal of neurochemistry.

[16]  C. Chinopoulos,et al.  Depolarization of In Situ Mitochondria Due to Hydrogen Peroxide‐Induced Oxidative Stress in Nerve Terminals , 1999, Journal of neurochemistry.

[17]  T. Magnuson,et al.  Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Parker,et al.  Secondary inhibition of 2‐ketoglutarate dehydrogenase complex by MPTP , 1998, Neuroreport.

[19]  J. Blass,et al.  Studies on the Pyruvate Dehydrogenase Complex in Brain with the Arylamine Acetyltransferase‐Coupled Assay , 1982, Journal of neurochemistry.

[20]  T. Dawson,et al.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Beal,et al.  Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons , 1996, Nature Medicine.

[22]  J. Blass,et al.  The α-ketoglutarate dehydrogenase complex in neurodegeneration , 2000, Neurochemistry International.

[23]  L. Toral-Barza,et al.  The role of cytosolic free calcium in the regulation of pyruvate dehydrogenase in synaptosomes , 2004, Neurochemical Research.

[24]  D. Hamar,et al.  Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. , 1985, Toxicology letters.

[25]  M. Gurney,et al.  Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.

[26]  M. Beal,et al.  Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.

[27]  R. Porter,et al.  Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat Striatum , 1993, Journal of neurochemistry.

[28]  B. Kristal,et al.  Metabolic Impairment Induces Oxidative Stress, Compromises Inflammatory Responses, and Inactivates a Key Mitochondrial Enzyme in Microglia , 1999, Journal of neurochemistry.

[29]  B. Rosen,et al.  Involvement of Free Radicals in Excitotoxicity In Vivo , 1995, Journal of neurochemistry.

[30]  N. Hattori,et al.  An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease , 1994 .

[31]  L. Tremblay,et al.  Experimental Models of Parkinson’s Disease , 2002, Annales pharmaceutiques francaises.

[32]  C. Epstein,et al.  3‐Nitropropionic Acid Neurotoxicity Is Attenuated in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1995, Journal of neurochemistry.

[33]  D. Gould,et al.  BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACID , 1982, Neuropathology and applied neurobiology.

[34]  H. Joenje,et al.  Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia. , 1990, The Journal of biological chemistry.

[35]  S. Sorbi,et al.  Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain , 1983, Annals of neurology.

[36]  J. Blass,et al.  The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. , 2000, Neurochemistry international.

[37]  T. Alston,et al.  3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[38]  O. Andreassen,et al.  Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease , 2001, Journal of neurochemistry.

[39]  G. Fiskum,et al.  Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state , 2003, Journal of neurochemistry.

[40]  Hui Zhang,et al.  Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme. , 2002, Biochimica et biophysica acta.

[41]  H. Joenje,et al.  Characterization of oxygen-resistant Chinese hamster ovary cells. III. Relative resistance of succinate and alpha-ketoglutarate dehydrogenases to hyperoxic inactivation. , 1991, Free radical biology & medicine.

[42]  A. Kingsbury,et al.  Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson’s disease , 2003, Neurochemistry International.

[43]  S. Ohta,et al.  Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease , 1990, Journal of the Neurological Sciences.

[44]  J. Schulz,et al.  Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity , 1995, Experimental Neurology.

[45]  B. Hyman,et al.  Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate , 1993, Journal of neurochemistry.

[46]  D. J. Porter,et al.  3-Carbanionic substrate analogues bind very tightly to fumarase and aspartase. , 1980, The Journal of biological chemistry.

[47]  M. Beal,et al.  Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Li,et al.  Oxidative metabolites of 5-S-cysteinyldopamine inhibit the α-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease , 2000, Journal of Neural Transmission.

[49]  M. Beal,et al.  Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease , 1996, The Journal of Neuroscience.

[50]  M. Beal,et al.  Oxidative Stress in Huntington's Disease , 1999, Brain pathology.

[51]  J. Blass,et al.  Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. , 1994, Annals of neurology.

[52]  L. Lannfelt,et al.  A DLST genotype associated with reduced risk for Alzheimer’s disease , 1999, Neurology.

[53]  B. Hassel,et al.  Selective Inhibition of the Tricarboxylic Acid Cycle of GABAergic Neurons with 3‐Nitropropionic Acid In Vivo , 1995, Journal of neurochemistry.

[54]  S. Ohta,et al.  Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain , 2003, The EMBO journal.

[55]  B. Hyman,et al.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  Y. Mizuno,et al.  Association between the gene encoding the E2 subunit of the α‐ketoglutarate dehydrogenase complex and Parkinson's disease , 1998, Annals of neurology.

[57]  O. Arrigoni,et al.  Limitations of the Phenazine Methosulphate Assay for Succinic and Related Dehydrogenases , 1962, Nature.